SCHEMBL4456504

SCHEMBL4456504

Nc1cc(=O)[nH]c(=S)n1-c1cc(F)ccc1F

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.56
KMT2A Q03164 4/20 0.56
HSD17B10 Q99714 3/20 0.50
MAPT P10636 3/20 0.50
MEN1 O00255 3/20 0.50
POLB P06746 1/20 0.50
GAA P10253 1/20 0.48
HPGD P15428 3/20 0.48
ALOX15 P16050 2/20 0.41
TSHR P16473 2/20 0.41
MPO P05164 2/20 0.41
MTNR1A P48039 1/20 0.39
MTNR1B P49286 1/20 0.39
RECQL P46063 1/20 0.37
CA12 O43570 2/20 0.37
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
CA9 Q16790 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.36
KDR P35968 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4457119 0.78 HSD17B10 (0.43) ALDH1A1KMT2AHSD17B10MAPTMEN1
SCHEMBL4456873 0.77 GAA (0.69) ALDH1A1KMT2AHSD17B10MAPTMEN1
SCHEMBL4502462 0.72 ALDH1A1 (0.69) ALDH1A1KMT2AHSD17B10MAPTMEN1
SCHEMBL4498185 0.71 ALDH1A1 (0.68) ALDH1A1KMT2AHSD17B10MAPTMEN1
SCHEMBL4500342 0.71 MAPT (0.68) ALDH1A1KMT2AMAPTMEN1POLB
SCHEMBL4338497 0.70 MPO (0.56) KMT2AHSD17B10MAPTMEN1POLB
SCHEMBL7083963 0.70 ALDH1A1 (0.66) ALDH1A1KMT2AHSD17B10MAPTMEN1
SCHEMBL4511434 0.70 GAA (0.54) ALDH1A1KMT2AHSD17B10MAPTMEN1
SCHEMBL4489566 0.69 GAA (0.67) ALDH1A1KMT2AMAPTMEN1GAA
SCHEMBL7088161 0.68 GAA (0.55) ALDH1A1KMT2AHSD17B10MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090286813-A1 Thioxanthine Derivatives and Their Use as Inhibitors of MPO ASTRAZENECA AB (SE) 2009-11-19 US disclosed
EP-2010534-A1 THIOXANTHINE DERIVATIVES AND THEIR USE AS INHIBITORS OF MPO AstraZeneca AB (SE) 2009-01-07 EP disclosed
WO-2007120097-A1 THIOXANTHINE DERIVATIVES AND THEIR USE AS INHIBITORS OF MPO ASTRAZENECA AB (SE) 2007-10-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286813-A1 Thioxanthine Derivatives and Their Use as Inhibitors of MPO MPO, XDH, EPX ALDH1A1 296/4885KMT2A 2979/4885HSD17B10 1182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.